VNDA Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

$16.02  -0.20 (-1.23%)
As of 12/06/2021 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/12/2006
Outstanding shares:  55,712,230
Average volume:  412,938
Market cap:   $923,151,651
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    921659108
ISIN:        US9216591084
Sedol:      B12W3P6
Valuation   (See tab for details)
PE ratio:   26.37
PB ratio:   1.83
PS ratio:   3.44
Return on equity:   6.95%
Net income %:   12.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy